Literature DB >> 18536936

Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.

Qin Yuan1, Pin Dong Li, Ben Hui Li, Xian Zi Yang, Shuang Bing Xu, Xiao Hong Liu, Fu Xiang Zhou, Wen Jie Zhang.   

Abstract

PURPOSE: To investigate potential differences in the expression of Stat6 regulatory genes that may influence IL-4/Stat6 activities (phenotypes) in colon cancer cells.
METHODS: RT-PCR method was employed to examine the constitutive mRNA expression of Stat6 negative regulators SOCS-1 and SHP-1, and positive regulator PP2A in colon cancer cell lines HT-29 and Caco-2. Stat6 protein expression and nuclear phosphorylation were detected using Western blotting.
RESULTS: Caco-2 cells carrying inactive Stat6(null) phenotype showed normal constitutive expression of Stat6 but decreased phosphorylation of nuclear Stat6 compared with HT-29 cells carrying active Stat6(high) phenotype. Stat6(null) Caco-2 cells expressed increased levels of mRNA and protein of SOCS-1 and SHP-1, and decreased mRNA expression of PPP2CA and PPP2CB, encoding two critical subunits of PP2A.
CONCLUSIONS: Constitutively increased expression of Stat6 negative regulators SOCS-1 and SHP-1, together with decreased expression of positive regulator PP2A, may play a role in forming the inactive Stat6(null) phenotype in colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536936     DOI: 10.1007/s00432-008-0429-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  38 in total

Review 1.  Atopy and asthma: genetic variants of IL-4 and IL-13 signalling.

Authors:  I Shirakawa; K A Deichmann; I Izuhara; I Mao; C N Adra; J M Hopkin
Journal:  Immunol Today       Date:  2000-02

2.  IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms.

Authors:  M K Levings; J W Schrader
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 3.  JAKs, STATs and Src kinases in hematopoiesis.

Authors:  Sushil G Rane; E Premkumar Reddy
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

Review 4.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

5.  Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice.

Authors:  K Takeda; M Kamanaka; T Tanaka; T Kishimoto; S Akira
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 6.  The role of constitutively active Stat6 in leukemia and lymphoma.

Authors:  Heather A Bruns; Mark H Kaplan
Journal:  Crit Rev Oncol Hematol       Date:  2005-10-05       Impact factor: 6.312

7.  Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.

Authors:  S J Haque; P C Harbor; B R Williams
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 8.  Protein phosphatase 2A: variety of forms and diversity of functions.

Authors:  K Lechward; O S Awotunde; W Swiatek; G Muszyńska
Journal:  Acta Biochim Pol       Date:  2001       Impact factor: 2.149

9.  STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells.

Authors:  Mingsheng Zhang; Yunfeng Zhou; Conghua Xie; Fuxiang Zhou; Yun Chen; Guang Han; Wen Jie Zhang
Journal:  Cancer Lett       Date:  2006-01-04       Impact factor: 8.679

Review 10.  Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha; Virginia Clements; Samudra I Dissanayake; Seth Miller; Cordula Davis; Erika Danna
Journal:  Cancer Immunol Immunother       Date:  2003-10-30       Impact factor: 6.968

View more
  7 in total

Review 1.  Implications of corticotropin releasing factor in targeted anticancer therapy.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  J Pharm Pract       Date:  2010-02-17

Review 2.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

3.  DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells.

Authors:  Shuang Bing Xu; Xiao Hong Liu; Ben Hui Li; Yan Zhang; Jia Yuan; Qin Yuan; Pin Dong Li; Xian Zi Yang; Feng Li; Wen Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-24       Impact factor: 4.553

4.  PP2ACdc55 dephosphorylates Pds1 and inhibits spindle elongation in S. cerevisiae.

Authors:  Shoily Khondker; Sam Kajjo; Devon Chandler-Brown; Jan Skotheim; Adam Rudner; Amy E. Ikui
Journal:  J Cell Sci       Date:  2020-07-29       Impact factor: 5.285

Review 5.  The role of suppressors of cytokine signalling in human neoplasms.

Authors:  Walid Sasi; Anup K Sharma; Kefah Mokbel
Journal:  Mol Biol Int       Date:  2014-03-16

Review 6.  Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression.

Authors:  Deepika Raman; Shazib Pervaiz
Journal:  Redox Biol       Date:  2019-01-14       Impact factor: 11.799

7.  Melatonin alleviates lipopolysaccharide (LPS) / adenosine triphosphate (ATP)-induced pyroptosis in rat alveolar Type II cells (RLE-6TN) through nuclear factor erythroid 2-related factor 2 (Nrf2)-driven reactive oxygen species (ROS) downregulation.

Authors:  Tao Zhou; Zhaodong Li; Hong Chen
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.